Xu, Hongli
Chen, Huixin
Hu, Junjie
Xiong, Zhiguo
Li, Dongqing
Wang, Shun
Yu, Jing
Funding for this research was provided by:
the medical talents of Wuhan health and family planning commission (2017[51])
Natural Science Foundation of Hubei Province (2017CFB567)
Article History
Received: 22 October 2021
Accepted: 1 August 2022
First Online: 13 August 2022
Declarations
:
: The study was carried out in accordance with ethical guidelines and approved by the Ethics committee of Hubei Cancer Hospital (ethical approval number: 2018[31]). Written informed consent was obtained from individual.
: Not applicable.
: All the authors aren’t employed by New Horizon Health Technology, China. The reagent kits ColoClear® in this research were supported by New Horizon Health Technology, China. The funding from the same company was paid for the fees for sample collection, medical examination of the subjects, colonoscopies and pathology. This arrangement has been reviewed and approved by the Hubei Cancer Hospital in accordance with its conflict of interest polices.